Journal article
NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates
Frontiers in immunology, Vol.10, pp.1890-1890
08/23/2019
DOI: 10.3389/fimmu.2019.01890
PMCID: PMC6716214
PMID: 31507586
Abstract
Background:
A previously proposed immune risk profile (IRP), based on T cell phenotype and CMV serotype, is associated with mortality in the elderly and increased infections post-kidney transplant. To evaluate if NK cells contribute to the IRP and if the IRP can be predicted by a clinical T cell functional assays, we conducted a cross sectional study in renal transplant candidates to determine the incidence of IRP and its association with specific NK cell characteristics and ImmuKnow® value.
Material and Methods:
Sixty five subjects were enrolled in 5 cohorts designated by age and dialysis status. We determined T and NK cell phenotypes by flow cytometry and analyzed multiple factors contributing to IRP.
Results:
We identified 14 IRP+ [CMV seropositivity and CD4/CD8 ratio < 1 or being in the highest quintile of CD8+ senescent (28CD–/CD57+) T cells] individuals equally divided amongst the cohorts. Multivariable linear regression revealed a distinct IRP+ group. Age and dialysis status did not predict immune senescence in kidney transplant candidates. NK cell features alone could discriminate IRP– and IRP+ patients, suggesting that NK cells significantly contribute to the overall immune status in kidney transplant candidates and that a combined T and NK cell phenotyping can provide a more detailed IRP definition. ImmuKnow® value was negatively correlated to age and significantly lower in IRP+ patients and predicts IRP when used alone or in combination with NK cell features.
Conclusion:
NK cells contribute to overall immune senescence in kidney transplant candidates.
Details
- Title: Subtitle
- NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates
- Creators
- David DeWolfe - Beth Israel Deaconess Medical CenterMalika Aid - Beth Israel Deaconess Medical CenterKevin McGann - Beth Israel Deaconess Medical CenterJoshua Ghofrani - Beth Israel Deaconess Medical CenterEmma Geiger - Beth Israel Deaconess Medical CenterCatherine Helzer - Beth Israel Deaconess Medical CenterShaily Malik - Beth Israel Deaconess Medical CenterSteve Kleiboeker - Viracor-Eurofins, Lee's Summit, MO, United States.Stephanie Jost - Beth Israel Deaconess Medical CenterChen Sabrina Tan - Beth Israel Deaconess Medical Center
- Resource Type
- Journal article
- Publication Details
- Frontiers in immunology, Vol.10, pp.1890-1890
- DOI
- 10.3389/fimmu.2019.01890
- PMID
- 31507586
- PMCID
- PMC6716214
- NLM abbreviation
- Front Immunol
- ISSN
- 1664-3224
- eISSN
- 1664-3224
- Publisher
- Frontiers Media S.A
- Grant note
- Roche Organ Transplant Research Foundation National Institute of Neurological Disorders and Stroke
- Language
- English
- Date published
- 08/23/2019
- Academic Unit
- Iowa Neuroscience Institute; Internal Medicine
- Record Identifier
- 9984366280602771
Metrics
10 Record Views